Discover a study where findings highlighted the effectiveness of low-dose oral minoxidil as an alternative to topical ...

Hair loss is a widespread issue, often causing significant distress. While some embrace baldness as "the new sexy," many ...

A receding hairline may be common — about two-thirds of men start losing their hair by age 35 — but that doesn’t make it any ...

Panelists discuss how the introduction of Janus kinase (JAK) inhibitor therapies will likely change treatment algorithms for alopecia areata (AA), with insights on how payers should plan for coverage ...

Panelists discuss how the Bayesian network meta-analysis showed which Janus kinase (JAK) inhibitors were most effective in reducing Severity of Alopecia Tool (SALT) scores in alopecia areata (AA), ...

A young woman began noticing bald patches on her head last year and discovered she had alopecia - now she is on a mission to ...

Alopecia areata, ringworm, and chemotherapy are among the most common causes of a bald spot or patch in the beard. Treatment can vary depending on the underlying cause of a bald patch in the beard.

Thinning hair is reversible and can fill out again, depending on the cause. Learn about hormonal hair loss, the role of ...

Convenient, pain-free, and drug-free, red light hair-growth devices are quickly becoming a go-to treatment for hair loss—so ...

Olumiant (baricitinib) is a prescription drug used to treat severe alopecia areata. It’s typically used when hair loss from this condition affects more than 50% of the scalp. Olumiant is a brand ...

Q32 Bio has put a stop to a Phase II trial of its former lead renal disease candidate as it pivots focus over to its alopecia areata treatment, bempikibart, amid a corporate restructure and job cuts.